StudyFinder
Clear

Search Results Within Category "Cancer"

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories

Suggestions within category "Cancer"

Bladder Cancer Blood Cancer Brain Cancer Breast Cancer Cancer Survivors Childhood Cancer Colon Cancer Genetic Cancer Syndromes Head and Neck Cancer Kidney Cancer Liver Cancer Lung Cancer Phase I Clinic Prostate Cancer Soft Tissue and Bone Cancer Stomach Cancer
1 Study Matches

MT2015-25: Tandem Myeloablative Consolidation Therapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma

To evaluate 3 year progression free survival (PFS) rate of high-risk neuroblastoma patients after treatment with a tandem consolidation of Thiotepa/ Cyclophosphamide and PBSC rescue followed by Carboplatin/Etoposide/ Melphalan (CEM) and PBSC rescue, as compared to historical controls of a single CEM consolidation course with PBSC rescue.

Status: Recruiting
Contact(s):

Holly Franceen - hfrancee@umn.edu

Principal Investigator: Ashish Gupta
Age: Not specified
Phase: PHASE2
Healthy Volunteers:
This study is NOT accepting healthy volunteers
System ID: 16776
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• less than 30 years old when diagnosis of neuroblastoma is made
• no uncontrolled infection
• recovered from acute toxicities of last cycle of induction chemotherapy
• see link to clinicaltrials.gov for complete inclusion and exclusion criteria
Conditions: Cancer
Keywords: Neuroblastoma
I'm interested
Share via email
See this study on ClinicalTrials.gov